• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    110 Biggest Movers From Friday

    5/16/22 5:23:29 AM ET
    $AFI
    $AFRM
    $AI
    $ALT
    Building Products
    Capital Goods
    Finance: Consumer Services
    Finance
    Get the next $AFI alert in real time by email

    Gainers

    • ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
    • PolarityTE, Inc. (NASDAQ:PTE) gained 44.5% to settle at $0.2117. The U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to PolarityTE’s (NASDAQ:PTE) SkinTE under the its open investigational new drug application (IND).
    • Veru Inc. (NASDAQ:VERU) shares surged 44% to close at $13.00 on Friday after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) jumped 42.8% to settle at $0.23. The company recently reported a net loss of $13.8 million for the three months ended March 31, 2022.
    • View, Inc. (NASDAQ:VIEW) gained 38.7% to close at $0.6501. View recently in a 10-Q filing said it does not currently have adequate financial resources to fund its forecasted operating costs and will look to raise capital.
    • Inotiv, Inc. (NASDAQ:NOTV) climbed 38.4% to close at $16.55 after the company reported better-than-expected Q2 results.
    • Amyris, Inc. (NASDAQ:AMRS) gained 37.2% to close at $2.36. Amyris recently reported a drop in Q1 EPS and sales.
    • Leap Therapeutics, Inc. (NASDAQ:LPTX) jumped 34.6% to settle at $1.31. Leap Therapeutics posted a Q1 net loss of $10.4 million.
    • Expensify, Inc. (NASDAQ:EXFY) climbed 34.5% to settle at $20.49 after the company posted Q1 results and announced a $50 million buyback program.
    • Molecular Data Inc. (NASDAQ:MKD) gained 34.5% to close at $0.1224.
    • Duolingo, Inc. (NASDAQ:DUOL) jumped 34% to settle at $89.77 after the company reported better-than-expected Q1 EPS and sales results.
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) gained 33.9% to close at $0.2250.
    • A2Z Smart Technologies Corp. (NASDAQ:AZ) rose 33.8% to settle at $4.63.
    • Lightspeed Commerce Inc. (NYSE:LSPD) surged 32.2% to close at $21.37.
    • PagSeguro Digital Ltd. (NYSE:PAGS) gained 31.8% to close at $13.47.
    • Payoneer Global Inc. (NASDAQ:PAYO) rose 31.4% to close at $4.73 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 sales guidance above analyst estimates.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) shares jumped 31.4% to settle at $23.71 after the company reported upbeat results for its third quarter and raised its revenue forecast for the fiscal year. The company also announced a multi-year extension of its partnership in the U.S. with Shopify.
    • Hippo Holdings Inc. (NASDAQ:HIPO) rose 30.7% to settle at $1.62 following Q1 results.
    • Vaccitech plc (NASDAQ:VACC) gained 30.1% to close at $4.02. HC Wainwright & Co. maintained Vaccitech with a Buy and lowered the price target from $23 to $22.
    • indie Semiconductor, Inc. (NASDAQ:INDI) rose 28.5% to close at $6.94 after the company reported better-than-expected Q1 EPS and sales results.
    • Viridian Therapeutics, Inc. (NASDAQ:VRDN) gained 28% to close at $13.52 following earnings.
    • PLx Pharma Inc. (NASDAQ:PLXP) rose 27.6% to settle at $2.59 following narrower-than-expected Q1 loss.
    • Celularity Inc. (NASDAQ:CELU) climbed 27.2% to close at $7.34.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) rose 25.3% to settle at $0.9099.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) jumped 25% to close at $1.85.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) shares gained 24.9% to close at $10.69 after a 13D filing showed Samuel Bankman-Fried, founder and CEO of FTX crypto exchange, disclosed a 7.6% stake in the company.
    • Stryve Foods, Inc. (NASDAQ:SNAX) rose 24.7% to settle at $1.11 after the company reported better-than-expected Q1 EPS and sales results.
    • Momentus Inc. (NASDAQ:MNTS) jumped 24.7% to close at $2.93. Momentus recently posted a Q1 loss of $0.34 per share.
    • KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) gained 24.7% to close at $4.95. KLX Energy Services recently posted Q1 sales of $152.30 million.
    • Beyond Meat, Inc. (NASDAQ:BYND) climbed 24.6% to close at $31.24. Beyond Meat recently reported worse-than-expected Q1 EPS and sales results.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) gained 24.4% to settle at $0.5593. Chembio Diagnostics recently posted a Q1 loss of $0.29 per share.
    • EQRx, Inc. (NASDAQ:EQRX) gained 24.2% to close at $4.11 following Q1 results.
    • Poshmark, Inc. (NASDAQ:POSH) jumped 23.8% to settle at $12.04 following Q1 results.
    • Aurora Mobile Limited (NASDAQ:JG) gained 23.8% to close at $1.04.
    • LightPath Technologies, Inc. (NASDAQ:LPTH) rose 23.7% to settle at $1.62 after reporting Q3 results.
    • IN8bio, Inc. (NASDAQ:INAB) jumped 23.6% to close at $2.78. IN8bio posted a Q1 loss of $0.33 per share.
    • Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) gained 23.2% to close at $12.47.
    • CleanSpark, Inc. (NASDAQ:CLSK) climbed 23% to close at $6.32. Cleanspark recently posted Q2 sales of $41.60 million.
    • Outset Medical, Inc. (NASDAQ:OM) gained 23% to settle at $24.86.
    • Sea Limited (NYSE:SE) surged 22.7% to close at $75.40.
    • Asana, Inc. (NYSE:ASAN) jumped 22.7% to settle at $24.37.
    • Dave Inc. (NASDAQ:DAVE) gained 22.7% to close at $2.87 following Q1 results.
    • Zai Lab Limited (NASDAQ:ZLAB) rose 22.7% to settle at $33.22. Zai Lab recently reported better-than-expected Q1 EPS and sales results.
    • Synchronoss Technologies, Inc. (NASDAQ:SNCR) jumped 22.7% to settle at $1.46.
    • Venus Concept Inc. (NASDAQ:VERO) gained 22.3% to settle at $0.8562.
    • Roivant Sciences Ltd. (NASDAQ:ROIV) jumped 23.1% to close at $3.46.
    • Nutex Health, Inc. (NASDAQ:NUTX) surged 22.4% to settle at $6.12.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) rose 22.2% to close at $7.00.
    • C3.ai, Inc. (NYSE:AI) climbed 22.1% to close at $17.78.
    • Porch Group, Inc. (NASDAQ:PRCH) gained 22.1% to settle at $4.64. The company recently posted upbeat quarterly sales.
    • Doma Holdings Inc. (NYSE:DOMA) surged 22% to close at $1.83.
    • Compass, Inc. (NYSE:COMP) jumped 21.9% to close at $5.45. Compass posted a Q1 loss of $0.45 per share.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) gained 21.8% to settle at $1.51. Galera Therapeutics recently announced topline results from Phase 2a AESOP trial of avasopasem for severe acute radiation-induced esophagitis in lung cancer patients receiving concurrent chemoradiotherapy.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 21.7% to close at $0.4475.
    • HUYA Inc. (NYSE:HUYA) gained 21.6% to settle at $3.89.
    • Arrival (NASDAQ:ARVL) jumped 21.3% to close at $1.94.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 21.2% to close at $2.46. Faraday Future posted a FY22 loss of $2.21 per share.
    • Dynavax Technologies Corporation (NASDAQ:DVAX) climbed 21.1% to close at $9.60. Dynavax Technologies is set to join S&P SmallCap 600.
    • ESS Tech, Inc. (NYSE:GWH) gained 21% to close at $4.95. ESS Tech posted a Q1 loss of $0.04 per share.
    • FingerMotion, Inc. (NASDAQ:FNGR) jumped 21% to settle at $1.50.
    • Field Trip Health Ltd. (NASDAQ:FTRP) gained 20.9% to close at $0.9430.
    • Oatly Group AB (NASDAQ:OTLY) climbed 20.8% to close at $3.71.
    • Blend Labs, Inc. (NASDAQ:BLND) rose 20.7% to close at $3.68 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 sales guidance.
    • Embark Technology, Inc. (NASDAQ:EMBK) gained 20.6% to settle at $2.34.
    • 1Life Healthcare, Inc. (NASDAQ:ONEM) rose 20.6% to close at $8.37.
    • Altimmune, Inc. (NASDAQ:ALT) gained 20.6% to settle at $5.16. Altimmune posted a Q1 loss of $0.44 per share.
    • DLocal Limited (NASDAQ:DLO) jumped 20.5% to close at $20.77.
    • Joby Aviation, Inc. (NASDAQ:JOBY) rose 20.3% to close at $5.33 after the company reported better-than-expected Q1 EPS results.
    • WeWork Inc. (NYSE:WE) jumped 20.1% to close at $6.76. WeWork posted a Q1 loss of $0.57 per share.
    • My Size, Inc. (NASDAQ:MYSZ) rose 19.9% to settle at $0.24 after the company reported Q1 EPS and sales results were up year over year.
    • Stem, Inc. (NYSE:STEM) gained 19.7% to close at $7.76.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) jumped 19.7% to settle at $0.8492. Mobiquity Technologies won a contract with KNEEDLESS as its data, programmatic advertising provider.
    • Immersion Corporation (NASDAQ:IMMR) surged 19.6% to close at $5.31 following upbeat quarterly earnings.
    • MicroStrategy Incorporated (NASDAQ:MSTR) gained 19.5% to settle at $204.57.
    • SomaLogic, Inc. (NASDAQ:SLGC) gained 19.1% to close at $5.42 after reporting Q1 results.
    • Silvergate Capital Corporation (NYSE:SI) jumped 19.1% to settle at $75.87.
    • TScan Therapeutics, Inc. (NASDAQ:TCRX) climbed 18.6% to settle at $2.49.
    • Laird Superfood, Inc. (NYSE:LSF) climbed 18.6% to close at $2.61following strong quarterly sales.
    • Bill.com Holdings, Inc. (NASDAQ:BILL) climbed 18.6% to close at $118.54.
    • Lightwave Logic, Inc. (NASDAQ:LWLG) gained 17.1% to close at $8.12.
    • Cloudflare, Inc. (NYSE:NET) gained 17% to settle at $66.38.
    • Ryder System, Inc. (NYSE:R) gained 17% to close at $83.65. Ryder 13D Filing from HG Vora showed the company issued proposal to acquire all shares of company’s common stock at $86 per share.
    • Alpha and Omega Semiconductor Limited (NASDAQ:AOSL) gained 16.7% to close at $38.75 after it was announced the company will replace Mimecast in the S&P SmallCap 600.
    • The RealReal, Inc. (NASDAQ:REAL) climbed 16.5% to settle at $3.75 after dipping around 6% on Thursday.
    • Molecular Partners AG (NASDAQ:MOLN) gained 15.2% to close at $6.90 Molecular Partners recently said its partner Novartis expects the FDA may require additional clinical data for the Emergency Use Application for ensovibep.
    • CTI BioPharma Corp. (NASDAQ:CTIC) rose 14.8% to close at $4.20 following upbeat quarterly results.
    • Array Technologies, Inc. (NASDAQ:ARRY) climbed 14.2% to close at $7.08. Array Technologies recently reported Q1 earnings results and issued FY22 adjusted EPS guidance below estimates.
    • Graphite Bio, Inc. (NASDAQ:GRPH) gained 14% to close at $2.60 after the company posted a narrower Q1 loss.
    • McEwen Mining Inc. (NYSE:MUX) gained 9.1% to close at $0.5030. McEwen Mining recently posted a Q1 loss of $0.04 per share.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) gained 8.7% to close at $0.2337 after gaining around 8% on Thursday.

     

    Losers

    • LiqTech International, Inc. (NASDAQ:LIQT) shares tumbled 45.4% to close at $0.50 on Friday after the company priced its public offering of common stock and pre-funded warrants.
    • Actelis Networks Inc. (NASDAQ:ASNS) shares dipped 40% to close at $2.40 after the company priced its IPO at $4 per share.
    • Jupai Holdings Limited (NYSE:JP) dropped 36.4% to close at $0.4767.
    • Brilliant Earth Group, Inc. (NASDAQ:BRLT) fell 33.6% to close at $4.48 after the company reported issued Q2 and FY22 net sales guidance below analyst estimates.
    • Tenon Medical, Inc. (NASDAQ:TNON) fell 26.4% to close at $6.52.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) dropped 25.4% to close at $0.70. Vallon Pharmaceuticals announced a $3.9 million registered direct offering.
    • FIGS, Inc. (NYSE:FIGS) fell 25% to close at $9.64 after the company reported worse-than-expected Q1 adjusted EPS and sales results and cut FY22 sales guidance to below analyst estimates.
    • Armstrong Flooring, Inc. (NYSE:AFI) dipped 18.7% to settle at $0.3250.
    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) fell 18.4% to close at $2.00. Direct Digital posted a Q1 loss of $0.09 per share.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) dropped 16.7% to close at $0.4404.
    • Sky Harbour Group Corporation (NYSE:SKYH) fell 16.2% to close at $7.23 after reporting Q1 results.
    • Enfusion, Inc. (NYSE:ENFN) fell 16% to close at $8.40 after the company reported worse-than-expected Q1 EPS results.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) dropped 15.6% to close at $5.66 following Q1 earnings.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares fell 15.4% to close at $0.1879. Salarius Pharmaceuticals posted a Q1 loss of $0.13 per share.
    • Xponential Fitness, Inc. (NYSE:XPOF) fell 13.6% to close at $14.37 after reporting a loss for the first quarter.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 12.3% to close at $0.2153. Regulus Therapeutics posted a Q1 loss of $0.05 per share.
    • Kiromic BioPharma, Inc. (NASDAQ:KRBP) dropped 11.6% to settle at $0.3339. Kiromic BioPharma recently announced it will submit an amended Investigational New Drug Application for its first oncology cell therapy candidate Procel directly to the FDA in the second half of 2022.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) fell 9.7% to close at $0.2258. Stealth BioTherapeutics shares jumped around 32% on Thursday after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
    • Twitter, Inc. (NYSE:TWTR) fell 9.7% to close at $40.72. After running the hard mile to mobilize finances for his Twitter buy, Elon Musk said early Friday the deal is on hold.
    • Digimarc Corporation (NASDAQ:DMRC) fell 9.4% to close at $18.31 following weak quarterly results.
    Get the next $AFI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFI
    $AFRM
    $AI
    $ALT

    CompanyDatePrice TargetRatingAnalyst
    BILL Holdings Inc.
    $BILL
    2/6/2026$50.00 → $46.00Market Perform
    BMO Capital Markets
    Cloudflare Inc.
    $NET
    2/4/2026$199.00Neutral → Buy
    BTIG Research
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    LightPath Technologies Inc.
    $LPTH
    1/29/2026$15.00Buy
    Canaccord Genuity
    Altimmune Inc.
    $ALT
    1/28/2026$20.00Overweight
    Barclays
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    Strategy Inc
    $MSTR
    1/27/2026$213.00Overweight
    Cantor Fitzgerald
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    More analyst ratings

    $AFI
    $AFRM
    $AI
    $ALT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Reffkin Robert L. converted options into 1,154,593 shares and covered exercise/tax liability with 638,797 shares (SEC Form 4)

    4 - Compass, Inc. (0001563190) (Issuer)

    2/6/26 4:30:30 PM ET
    $COMP
    EDP Services
    Technology

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER Mccall Patrick

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:26 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by President and COO Rochlin Kate

    4 - IN8BIO, INC. (0001740279) (Issuer)

    2/6/26 4:30:23 PM ET
    $INAB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFI
    $AFRM
    $AI
    $ALT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for OPVEE issued to OPIANT PHARMACEUTICALS INC

    Submission status for OPIANT PHARMACEUTICALS INC's drug OPVEE (ORIG-1) with active ingredient NALMEFENE has changed to 'Approval' on 05/22/2023. Application Category: NDA, Application Number: 217470, Application Classification: Type 3 - New Dosage Form

    5/24/23 11:39:07 AM ET
    $OPNT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 22, 2023 - FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose

    For Immediate Release: May 22, 2023 Today, the U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older. This is the first FDA approval of nalmefene hydrochloride nasal spray for health care and community use. “The agency continues to advance the FDA

    5/22/23 4:58:14 PM ET
    $OPNT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OPVEE (nalmefene) issued to OPIANT PHARMACEUTICALS INC

    Submission status for OPIANT PHARMACEUTICALS INC's drug OPVEE (nalmefene) (ORIG-1) with active ingredient OPVEE (nalmefene) has changed to 'Approval' on 05/22/2023. Application Category: NDA, Application Number: 217470, Application Classification: Type 3 - New Dosage Form

    5/22/23 4:51:13 PM ET
    $OPNT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AFRM
    $AI
    $ALT
    SEC Filings

    View All

    SEC Form 424B5 filed by Momentus Inc.

    424B5 - Momentus Inc. (0001781162) (Filer)

    2/6/26 4:53:27 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    SEC Form S-8 POS filed by Venus Concept Inc.

    S-8 POS - Venus Concept Inc. (0001409269) (Filer)

    2/6/26 4:47:21 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Venus Concept Inc.

    S-8 POS - Venus Concept Inc. (0001409269) (Filer)

    2/6/26 4:47:21 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    $AFI
    $AFRM
    $AI
    $ALT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pisano Wayne bought $20,410 worth of shares (5,000 units at $4.08), increasing direct ownership by 59% to 13,498 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/9/26 4:10:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Sohn Catherine A. bought $2,118 worth of shares (500 units at $4.24), increasing direct ownership by 50% to 1,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/5/26 4:05:39 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Thompson Michael N. Jr. bought $14,564 worth of shares (1,100 units at $13.24) (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    1/2/26 4:43:46 PM ET
    $JOBY
    Aerospace
    Industrials

    $AFI
    $AFRM
    $AI
    $ALT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ryder Declares Quarterly Cash Dividend

    Company Pays Dividend for 198th Consecutive Quarter The Board of Directors of Ryder System, Inc. (NYSE:R) declared a regular quarterly cash dividend of $0.91 per share of common stock to be paid on March 20, 2026 to shareholders of record on February 17, 2026. This is Ryder's 198th consecutive quarterly cash dividend – marking more than 49 years of uninterrupted dividend payments. About Ryder System, Inc. Ryder System, Inc. (NYSE:R) is a fully integrated port-to-door logistics and transportation company. It provides supply chain, dedicated transportation, and fleet management solutions, including warehousing and distribution, contract packaging and manufacturing, e-commerce fulfillm

    2/6/26 4:30:00 PM ET
    $R
    Rental/Leasing Companies
    Consumer Discretionary

    Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025

    Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 P<0.0001). Brepocitinib demonstrated rapid, deep and sustained improvements across all other efficacy endpoints measured with consistent safety profilePriovant plans to progress CS to a pivotal program with a Phase 3 study starting in calendar year 2026 following engagement with the FDA, representing the third indication with a pivotal program for brepocitinib New Drug Application (NDA) was submitted to the FDA for brepocitinib in dermatomyositis (DM). Topline data from Phase 3 studies in non-infectiou

    2/6/26 7:00:00 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)

    Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ 21.6 P<0.0001)All brepocitinib 45 mg patients achieved a clinically meaningful response, with 100% demonstrating at least a 10-point improvement on CSAMI-AOn the Investigator's Global Assessment (IGA), 69% percent of brepocitinib 45 mg patients compared to 0% of placebo patients achieved the gold standard two-point improvement to "Clear" (0) or "Almost Clear" (1) (Δ 69% P=.0047)Brepocitinib 15 mg patients also improved considerably, with numerically similar improvement to the 45 mg arm on lower-bar endpoin

    2/6/26 7:00:00 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AFRM
    $AI
    $ALT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Bill.com with a new price target

    BMO Capital Markets reiterated coverage of Bill.com with a rating of Market Perform and set a new price target of $46.00 from $50.00 previously

    2/6/26 6:48:02 AM ET
    $BILL
    EDP Services
    Technology

    Cloudflare upgraded by BTIG Research with a new price target

    BTIG Research upgraded Cloudflare from Neutral to Buy and set a new price target of $199.00

    2/4/26 8:24:40 AM ET
    $NET
    Computer Software: Prepackaged Software
    Technology

    Affirm upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Affirm from Equal-Weight to Overweight and set a new price target of $76.00

    2/3/26 6:49:01 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AFI
    $AFRM
    $AI
    $ALT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology

    $AFI
    $AFRM
    $AI
    $ALT
    Financials

    Live finance-specific insights

    View All

    Ryder Declares Quarterly Cash Dividend

    Company Pays Dividend for 198th Consecutive Quarter The Board of Directors of Ryder System, Inc. (NYSE:R) declared a regular quarterly cash dividend of $0.91 per share of common stock to be paid on March 20, 2026 to shareholders of record on February 17, 2026. This is Ryder's 198th consecutive quarterly cash dividend – marking more than 49 years of uninterrupted dividend payments. About Ryder System, Inc. Ryder System, Inc. (NYSE:R) is a fully integrated port-to-door logistics and transportation company. It provides supply chain, dedicated transportation, and fleet management solutions, including warehousing and distribution, contract packaging and manufacturing, e-commerce fulfillm

    2/6/26 4:30:00 PM ET
    $R
    Rental/Leasing Companies
    Consumer Discretionary

    Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025

    Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 P<0.0001). Brepocitinib demonstrated rapid, deep and sustained improvements across all other efficacy endpoints measured with consistent safety profilePriovant plans to progress CS to a pivotal program with a Phase 3 study starting in calendar year 2026 following engagement with the FDA, representing the third indication with a pivotal program for brepocitinib New Drug Application (NDA) was submitted to the FDA for brepocitinib in dermatomyositis (DM). Topline data from Phase 3 studies in non-infectiou

    2/6/26 7:00:00 AM ET
    $ROIV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Payoneer to Report Fourth Quarter and Full Year 2025 Results on February 26, 2026

    NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Payoneer Global Inc. (NASDAQ:PAYO), the global financial technology company powering business growth across borders, will report its Fourth Quarter and Full Year 2025 financial results on Thursday, February 26, 2026, before the market opens. Senior management will also host a conference call and earnings webcast to discuss financial results at 8:30 a.m. Eastern Time the same day. A live webcast and replay of the event will be available on the Payoneer Investor Relations website at https://investor.payoneer.com. About Payoneer Payoneer is

    2/5/26 4:30:00 PM ET
    $PAYO
    Real Estate

    $AFI
    $AFRM
    $AI
    $ALT
    Leadership Updates

    Live Leadership Updates

    View All

    Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600:  S&P MidCap 400 constituent Ciena Corp. (NYSE:CIEN) will replace Dayforce Inc. (NYSE:DAY) in the S&P 500, S&P SmallCap 600 constituent Arrowhead Pharmaceuticals Inc. (NASD: ARWR) will replace Ciena in the S&P MidCap 400, and ADT Inc. (NYSE:ADT) will replace Arrowhead Pharmaceuticals in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 9. Thoma Bravo L.P. acquired Dayforce in a deal that closed today.OneSpaWorld Holdings Ltd. (NASD: OSW) will replace Dynavax Technologies Corp. (NASD: DVAX) in the S&P SmallCap 600 effec

    2/4/26 6:15:00 PM ET
    $ADT
    $ARWR
    $CIEN
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Coldwell Banker Real Estate Announces 2025 Year-End Award Winners

    The brand recognizes the top affiliated sales professionals, teams, offices and companies who have demonstrated exceptional performance across multiple sales categories in the past year MADISON, N.J., Jan. 29, 2026 /PRNewswire/ -- Coldwell Banker Real Estate LLC today announced the 2025 recipients of its annual year-end awards, recognizing top‑ranking performers whose achievements exemplify the highest standards of excellence across the Coldwell Banker® network. "Each year, the dedication of the Coldwell Banker real estate professionals, teams, and offices elevates the standar

    1/29/26 10:00:00 AM ET
    $COMP
    EDP Services
    Technology

    Dave Inc. Appoints Nima Khajehnouri to Board of Directors; Announces Board Leadership Transitions

    LOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced that Nima Khajehnouri, a distinguished leader in artificial intelligence and data engineering, has joined its Board of Directors, effective immediately. Mr. Khajehnouri will serve as a member of the Company's Audit Committee. Imran Khan, who has served on the Board since August 2023, is stepping down in conjunction with this appointment. Mr. Khajehnouri brings more than two decades' experience of leading engineering at some of the world's most influential technology companies. He currently serves as Vice President of Engineering at Meta, h

    1/20/26 5:27:46 PM ET
    $DAVE
    Finance: Consumer Services
    Finance